SCHEMBL6996735

SCHEMBL6996735

COc1ccc(C2C[C@H]2C(=O)O)cc1Cl

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.52
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
APP P05067 2/20 0.46
FFAR1 O14842 4/20 0.46
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
CA12 O43570 1/20 0.45
RXRA P19793 1/20 0.44
GAA P10253 1/20 0.44
PDE5A O76074 1/20 0.43
LTB4R Q15722 1/20 0.43
TAS1R3 Q7RTX0 1/20 0.42
TAS1R1 Q7RTX1 1/20 0.42
KDM1A O60341 1/20 0.42
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996736 1.00 ALDH1A1 (0.52) ALDH1A1MEN1KMT2AAPPFFAR1
SCHEMBL7002284 0.86 APP (0.55) KMT2AAPPFFAR1CA1CA2
SCHEMBL2952559 0.86 APP (0.55) KMT2AAPPFFAR1CA1CA2
SCHEMBL7002288 0.86 APP (0.55) KMT2AAPPFFAR1CA1CA2
SCHEMBL7002924 0.84 RXRA (0.49) APPFFAR1CA1CA2CA9
SCHEMBL10254282 0.84 RXRA (0.49) APPFFAR1CA1CA2CA9
SCHEMBL2722140 0.82 SLC6A2 (0.50) KMT2AAPPFFAR1CA1CA2
SCHEMBL2722142 0.82 SLC6A2 (0.50) KMT2AAPPFFAR1CA1CA2
SCHEMBL7000989 0.82 KDM1A (0.61) APPFFAR1CA1CA2CA9
SCHEMBL15669063 0.82 KDM1A (0.61) APPFFAR1CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0996621-B1 TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS ASTRAZENECA AB (SE) 2003-10-01 EP disclosed
US-6251910-B1 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists ASTRAZENECA UK LIMITED (GB) 2001-06-26 US disclosed